Skip to main content

Table 2 Outcome of nutritional and functional parameters in both groups in 12 months

From: The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patients

 

CDDP group

THD group

 

Baseline (n = 38)

6 months (n = 38)

12 months (n = 34)

Baseline (n = 30)

6 months (n = 30)

12 months (n = 29)

P

Dry weight (kg)

65 ± 15.0

63.9 ± 14.4

63.4 ± 14.7

66.2 ± 11.9

64.9 ± 11.5

65.5 ± 12.3

0.07

BMI (kg/m 2 )

23.7 ± 4.0

23.4 ± 3.7

23.0 ± 3.9

25.6 ± 4.13

25.1 ± 4.07

25.4 ± 4.2

0.07

Total body water (L)

44.4 ± 10.5

41 ± 9.6

43 ± 11

35.4 ± 6

33.5 ± 5.8 a

33.8 ± 5.9 a

0.02

Extracellular water (L)

20 ± 4.5

18.6 ± 4.3

19.7 ± 4

17.5 ± 3.2

16 ± 2.8 b

15.7 ± 2.4 b

0.04

Fat mass (kg)

11 ± 12.3

13 ± 11.8

11.4 ± 11

20 ± 9

21.4 ± 8.5

22.6 ± 9.4

0.03

Body cell mass (kg)

31 ± 9.6

28 ± 8.9

29.7 ± 10.3

22.5 ± 6.2

22.7 ± 5

22.7 ± 5.8

0.02

Phase angle, (°)

6.2 ± 1.3

6.2 ± 1.3

6.1 ± 1.4

5.0 ± 1.2

6 ± 0.9

5.8 ± 1.2

0.06

SBP (mmHg)

139 ± 18

132 ± 20

128 ± 15 b

136.8 ± 17.2

138.5 ± 18.5

139 ± 20.8

0.21

DBP (mmHg)

80 ± 12

73 ± 10

74 ± 9 c

71.6 ± 11.4

71.6 ± 10

72.9 ± 12.3

0.08

Serum creatinine (mg/dL)

6.4 ± 1.9

7.0 ± 2.5

7.8 ± 3.0 b

5.9 ± 1.8

7.8 ± 2.2

8.2 ± 2.4 b

0.05

B.U.N. (mg/dL)

68 ± 18

68 ± 16

70 ± 17

84.4 ± 18.5

77 ± 15.5

77 ± 22.9

0.003

GFR (mL/min)

7.8 ± 1.9

6.7 ± 2.3

6.3 ± 2.1 b

9.2 ± 4.2

-

-

-

eGFR (mL/min)

9.4 ± 2.9

8.4 ± 3.5 a

8.0 ± 3.4 b

10.3 ± 3.9

-

-

-

Total protein (g/dL)

6.7 ± 0.5

6.7 ± 0.5

6.8 ± 0.4

6.35 ± 0.52

6.4 ± 0.5

6.5 ± 0.43

0.004

Albumin (g/dL)

3.8 ± 0.4

3.9 ± 0.4

4.1 ± 0.4 b

3.6 ± 0.40

3.6 ± 0.37

3.7 ± 0.48

0.01

Transferrine (mg/dL)

219 ± 53

203 ± 72

222 ± 53

264 ± 94

249 ± 43

251 ± 61

0.001

C3 (mg/dL)

90 ± 20

91 ± 23

94 ± 23

99.6 ± 39.6

96 ± 35.7

95.9 ± 32

0.48

C4 (mg/dL)

24 ± 7

24 ± 8

26 ± 7

33 ± 28

29 ± 18

29 ± 30

0.26

Total IgG (mg/dL)

1599 ± 497

1590 ± 402

1543 ± 373

1440 ± 461

1482 ± 487

1409 ± 413

0.21

Lynphocytes/mm 3

1539 ± 651

1390 ± 831

1581 ± 537

1452 ± 811

1458 ± 622

1445 ± 580

0.38

  1. Legend: changes versus baseline: ap < 0.05; bp < 0.01; c< 0.03; P: ANOVA significance for treatment by time interaction.